Industry Updates: June 2014

June 2, 2014
Awards, successes, investments in new drugs, acquisitions and partnerships, sales meetings, and new hires: everything that makes up the news in the dental world.

Henry Schein Awarded 2014 William J. Gies Award
Henry Schein, Inc. was presented with the 2014 William J. Gies Award for Outstanding Achievement in the public or private partner category at a ceremony held recently during the American Dental Education Association (ADEA) Annual Session & Exhibition. Selected by the ADEA and the Geis Foundation, the award recognized Henry Schein for its work to advance oral health and oral health education around the world.

Stanley M. Bergman, chairman of the board and chief executive officer of Henry Schein, Inc., accepted the award on behalf of Henry Schein. “It is gratifying to have this wonderful recognition of our Company’s commitment to advancing access to global oral health care through public-private partnerships that engage all sectors of the oral health community,” said Mr. Bergman. “As a catalyst to the creation of these partnerships, we have been privileged to work closely with the ADEA and many other leading professional associations on a wide variety of initiatives through Henry Schein Cares, our global social responsibility program. We are confident that through our strong partnerships and sustained commitment, we can continue to enhance oral health care around the world.”

Public-private partnerships are the foundation of Henry Schein’s global corporate social responsibility model, which is carried out through its Henry Schein Cares program. The Company is committed to playing a catalyst role in the formation of public-private partnerships with its supplier partners, nongovernmental organizations (NGOs), government agencies, professional associations, and Team Schein in an effort to effectively mobilize action and collectively address global health issues. Successful public-private partnerships are pivotal to Henry Schein’s flagship outreach initiatives, including its more than a decade-long commitment as professional product sponsor of the American Dental Association’s Give Kids A Smile program; the Henry Schein Healthy Lifestyles, Healthy Communities program; the NYU College of Dentistry/Henry Schein Cares Global Student Outreach program; and the Henry Schein Cares Global Product Donation program.

IDEM Singapore 2014 record-breaking success
IDEM Singapore 2014 saw more than 500 exhibitors from 38 countries showcasing the latest innovations in clinical dentistry, dental technology and patient care across every segment of the dental market, covering restorative and preventive treatments, surgical procedures and equipment, orthodontics, endodontics, periodontics and laboratory tools. The IDEM Singapore trade fair was the largest staged at the Suntec Singapore Convention and Exhibition Centre since it was refurbished, and the first ever to fill both floors of exhibition space covering 16,000 sqm. The trade fair and conference welcomed 7,842 participants from 61 countries over three and a half days.

ESRO the Swiss manufacturer of dental care products, at IDEM Singapore for the second time, had an excellent experience according to their general manager, Mr Patrick Sutter: “IDEM Singapore has been excellent for us. We came from Switzerland to build contacts in Asian markets,” he said. “e've made some good contacts and had some good conversations. Every contact and every discussion has been fruitful. We do not sell direct here from the fair so the results will be afterwards, but we are positive there will be good results. We will definitely consider coming back.”

Henry Schein Sponsors 2014 Senior Dental Leaders Programme
Henry Schein, Inc. sponsored the eighth annual Senior Dental Leaders Programme held recently in London. Designed to develop high-level leadership and management capabilities in oral health leaders from around the globe, this year’s program gathered nearly 100 participants.

First conceptualized by Professor Raman Bedi, DDS, in 2007 at King’s College London, the Senior Dental Leaders Programme for 2014 was organized by the Global Child Dental Fund, King’s College London Dental Institute and the Harvard School of Dental Medicine.

Stanley M. Bergman, chairman of the board and chief executive officer of Henry Schein, addressed program participants, highlighting the importance of public-private collaboration between academia, clinical practitioners, government, non-governmental organizations (NGOs) and the dental industry in solving the global problem of inadequate oral health. “We all recognize that to effectively address the complex global issue of advancing oral health care around the world it will take all sectors of the oral health community working together towards a common goal,” said Mr. Bergman. “Henry Schein is committed to a global private-public partnership that includes dental educators, clinicians, government, non-governmental organizations and industry. Part of our commitment is our sponsorship of the Senior Dental Leaders Programme, which helps further empower oral health leaders, strengthen their networks of support, enable the sharing of best practices, and increase access to care around the world.”

The intensive multi-day conference brought together dental policy makers, national chief dental officers, representatives from NGOs, and academics, who work to forge an international collaborative network with the goal of advancing the mission of a cavity-free world for children at the local, state, and federal levels.

Delta Dental of New Jersey Invests in New Drug
Delta Dental of New Jersey has invested $5 million in C3 Jian, Inc. to support the company’s development of an antimicrobial drug that targets the bacteria responsible for tooth decay. It is one of several Delta Dental member companies and affiliated organizations that have made substantial investments in C3 Jian.

C3 Jian, Inc. is a private company focused on developing proprietary drugs with a focus on improving oral healthcare. Its lead product, called C16G2, is a proprietary peptide-based antimicrobial drug specifically targeting Streptococcus mutans, a bacterium responsible for dental caries, or tooth decay. Under a U.S. FDA Investigational New Drug Application, the company recently began a Phase 2 Clinical Trial to study C16G2 formulated as a mouth rinse, as well as a gel, for both dental tray and toothbrush applications.

“Tooth decay is the most common chronic disease of childhood, yet it’s nearly 100 percent preventable,” said Ronald Deblinger, DMD, chairman, Board of Trustees, Delta Dental of New Jersey. “This new treatment has the potential to help eradicate the disease and improve the oral health, and by connection the overall health, of people everywhere.”

Cantel Medical Corp. Named to Forbes 2013 “100 Best Small Companies in America”
For the second consecutive year, Cantel Medical Corp. was named to the Forbes list of the “100 Best Small Companies in America.” The Company was ranked number 67 on the Forbes 2013 list. Cantel’s president and CEO Andrew Krakauer stated, “We are pleased to have been recognized for the success the company has achieved both this year and over the past five years. I share this honor with our 1,300 hardworking and loyal employees. As a leader in the growing infection prevention and control market, the company has performed well despite the difficult economic environment. We are optimistic that Cantel is positioned for sustained growth in the future. Our entire organization has a great sense of pride in providing the products, services and the guidance to mitigate infection risks, improve safety, and ultimately help save lives.”

The Forbes rankings are based on one- and five-year earnings growth, sales growth, and return on equity. To qualify, companies must have sales between $5 million and $1 billion, and meet certain share price and other criteria. Forbes also considers a company’s stock performance with its industry peers during the last year.

Crosstex Acquires Sterilator Company, Inc.
Cantel Medical Corp., through its Crosstex subsidiary, has further expanded its sterility assurance monitoring business with the acquisition of Sterilator Company, Inc. Based in Cuba, N.Y., Sterilator Company is a high-quality manufacturer of biological indicators and supplies for sterility assurance products, which are used to accurately monitor the effectiveness of sterilization processes. Sterilator serves both the medical and industrial markets, and has been a long-time supplier of self-contained biological indicators, dual species spore strips and culture media to our dental and hospital healthcare disposable business.

Gary Steinberg, president and CEO of Crosstex, said, “This acquisition allows us to add one of our key long-standing suppliers of biological indicators to our portfolio, providing a strategic benefit to our overall sterility assurance monitoring business. I am also pleased that we will retain Sterilator’s current leadership, who will serve an integral role in new product development and R&D initiatives in sterility assurance.”

LED Imaging Announces Partnership with Ray Co., Ltd., (Samsung)
LED Imaging, the new dental imaging division of LED Dental Ltd. announced recently that it is partnering with Ray Co., Ltd., a subsidiary of Samsung, to sell, install, and provide support for the RAYSCAN α – Expert dental imaging system. The RAYSCAN α – Expert is a multi-function digital extraoral imaging system with 3-D cone beam computed tomography (CBCT), panoramic, and cephalometric capabilities. Ray Co. is the first partner to join LED Imaging’s product portfolio since the company announced its expansion into the dental imaging category and emergent product offerings.

“We are very excited about working with Ray Co. and Samsung to provide practitioners with a compact, yet powerful, CBCT imaging system to capture the crisp, high-quality images needed for diagnosis and treatment,” said Lamar Roberts, president of LED Imaging. “We understand what practitioners want and need, so partnerships like this give us an advantage to provide the best technology available in each product category.”

The RAYSCAN α – Expert’s 3D images are captured using an optimal 9 cm x 9 cm field of view, which is ideal for a wide variety of clinical applications. The system’s CMOS and Direct Deposition Cesium Iodide (CsI) Detector ensure practitioners can quickly capture high-quality, 16-bit DICOM images at a low radiation dose. To minimize error from patient positioning and movement, the system’s focal trough is stabilized and controlled through adaptive moving focus technology. The RAYSCAN α’s exclusive de-noising technology enhances image quality by removing noise that would otherwise blur the image.

“With the legal close of our business partnership with LED Imaging, we're one step closer to bringing oral health practitioners a strong manufacturer that offers greater dental products and access to more services in the U.S. market,” said Dr. Sangchul Lee, CEO of Ray Co. “As such, we’re proud to align our product with the LED Imaging brand due to its solid leadership team with both clinical and industry experience.”

Ray Co. is Samsung’s first subsidiary business venture in the dental technology industry. Samsung is a worldwide leader in technology and electronics. LED Imaging will offer nationwide service and technical support for the RAYSCAN α - Expert.

Guardian Diversifies Dental Business with Strategic Acquisition
The Guardian Life Insurance Company of America, a leading provider of employee benefits and one of the largest dental insurers in the United States, recently announced it has entered into an agreement to acquire Premier Access Insurance Company, a provider of dental coverage and care to employers and individuals with more than 634,000 members.

The acquisition strengthens Guardian’s existing Dental Preferred Provider Organization (PPO) and Dental Health Maintenance Organization (DHMO) network in several states, including California, Utah, Nevada, and Arizona. It also extends Guardian’s reach into the state-run Medicaid and Children's Health Insurance Program (CHIP) markets, which are expected to grow significantly due to expanded eligibility under the Affordable Care Act (ACA). Guardian will also gain a presence on six individual state exchanges, complementing its existing offering on 48 of the small business health (SHOP) exchanges.

“ACA is changing the dental benefits landscape. It is the responsibility of insurers such as Guardian to deliver cost-effective, quality dental care to more Americans where and how they are looking to be served,” said Dong Ahn, executive vice president, Guardian. “Guardian’s acquisition of Premier Access demonstrates our commitment to maintaining our position as a leading dental company while expanding our reach to serve more customers who are seeking access to dental insurance through Medicaid and the exchanges.”

Premier Access has approximately 620 employees, serves over 5,000 employer plans and operates 18 dental centers. As part of Guardian, Premier Access customers will gain access to Guardian’s nationwide dental network. Premier’s exchange and government-funded program businesses will expand nationally. The company was founded in 1989 and is based in Sacramento, California.

LED Dental Inc. Announces New Dealer Agreement in the Southeast Region
LED Dental Inc. announced that it has entered into a non-exclusive partnership with Atlanta Dental Supply Company and Nashville Dental, Inc. for distribution of the Company’s VELscope Vx Enhanced Oral Assessment System and product line within the United States market.

“It is an honor to partner with both Atlanta Dental and Nashville Dental for distribution within the Southeast,” said Lamar Roberts, president of LED Dental. “Both of these dealers have extensive networks that will maximize the potential for the VELscopeVx product line while providing cutting-edge technology to their customers.”

“We are excited to offer the market-leading adjunctive oral mucosal examination tool to our client base,” said Todd Brown, vice president of equipment for Nashville Dental. “The VELscope Vx is saving lives by discovering a wide range of oral abnormalities, including oral cancer, sooner. This technology is in high-demand in the dental industry, and we’re proud to add it to our portfolio.”

Straumann and botiss team up to provide complete dental regeneration solutions worldwide
At the ITI World Symposium in Geneva, Straumann and botiss announced their intention to combine their strengths to provide complete oral tissue regeneration solutions to dental professionals worldwide.

According to an agreement between the two companies, Straumann will have exclusive rights to distribute botiss regenerative system products initially in most western and central European countries and the Americas, with co-distribution in Germany. At the same time, botiss will receive rights to distribute Straumann’s unique regenerative product Emdogain in Germany as well as in parts of Eastern Europe and the Middle East. In addition, Straumann has been granted a call option to acquire botiss’ shares, which, if exercised, could lead to a stake in the German company of up to 30 percent in 2017.

Based in Berlin, botiss biomaterials is Europe’s second largest supplier of oral tissue regeneration products. Its full range of clinically proven, high quality solutions includes membranes for guided tissue and bone regeneration, a full range of bovine, allogenica, and synthetic bone graft materials, as well as soft-tissue-graft products. botiss is a fast-growing entrepreneurial company whose products are used in leading clinics across Europe and are backed by many years of clinical experience. The company prides itself in innovations, such as its maxgraft bonering for simultaneous implant placement and bone augmentation, as well as the maxgraft bonebuilder, a bone block customized for individual patients.

Straumann’s CEO, Marco Gadola commented: “botiss will enable us to offer an unparalleled range of regenerative solutions to support implant and periodontal procedures. Their quality, effectiveness, handling characteristics and clinical track record will have great appeal to our customers — as will the possibility to obtain every component for a complete solution from one company.”

The two companies plan to begin distributing the respective products in initial countries in October 2014 and will work together to expedite regulatory clearances in American and Asian markets.

Midmark Announces 2014 Dental Sterilizer Promotion and Partnership with Crosstex
Midmark Corporation recently announced the 2014 Dental Sterilizer Promotion and partnership with Crosstex. The promotion, themed Great Alone, Better Together, creates a “win-win” situation for dental professionals as two recognized industry leaders come together to deliver a complete sterilization and monitoring solution.

The promotion, which runs until June 30, 2014, offers dentists a holistic instrument processing solution with top-quality products and rebates ranging from $300 to $700, while also providing education, via the Crosstex Compliance Essentials Kit and CE course, on proper sterilization and patient safety — the upmost priority for both companies. For each eligible Midmark sterilizer purchased during the promotion, along with a sterilizer donation to Direct Relief, the customer will receive an additional $200 rebate.

“Having the right equipment and tools are two critical components for proper instrument processing; however, there is a gap between sterilization guidelines and how instruments are being processed in the dental office,” stated Cathy Klein, product manager for Midmark. “We want to provide the equipment, tools and education to ensure proper instrument processing for every dental facility.”

Important program dates:
Order period: April 1–June 30, 2014
Dentist’s shipment and invoice date must be between: April 1–July 15, 2014
Must claim incentives by: August 1, 2014
Donations to Direct Relief must be received by: August 31, 2014

Hu-Friedy Opens State-of-the-Art Dental Product Showroom
Hu-Friedy, a global leader in the manufacturing of dental instruments and products, officially opened its new dental showroom at its West Campus facility in Des Plaines, Ill. Des Plaines Mayor Matthew Bogusz and other community officials joined Ken Serota, Hu-Friedy president, for the grand opening event.

Located minutes from O’Hare airport, the showroom is the ideal setting for dental professionals, clinical educators, and distributor partners to experience Hu-Friedy’s advanced technology in a hands-on practice setting. Visitors will experience firsthand how Hu-Friedy’s quality instrumentation, small equipment, infection prevention products, and Instrument Management System can be incorporated into their practices.

“At Hu-Friedy, everything we do centers around helping dental professionals perform at their best, and the showroom is no exception. We now have a dedicated, extraordinary space where we can offer customers the opportunity to experience all of Hu-Friedy’s products,” said Ken Serota. “Our customers have a wide range of clinical needs and preferences and the showroom makes it easy to see the possibilities, discover what works best for them, and learn how to incorporate our quality instruments and equipment into their practice.”

Featuring three dental operatories, a sterilization center, product displays, and conference area, the showroom offers access to Hu-Friedy’s full line of products, ranging from periodontal and power scaling to surgical and infection prevention. The Instrument Management System, which Hu-Friedy pioneered nearly 20 years ago to provide safe and efficient instrument processing, is optimally demonstrated in the showroom.

Practitioners visiting the facility can meet with Hu-Friedy‘s regional account representative or clinical education manager for individual consultations. Building on its strong educational focus, Hu-Friedy plans to collaborate with its network of 600 global Key Opinion Leaders to offer Continuing Education seminars, training courses and exclusive events throughout the year in the showroom.

Stratasys Establishes Dental Advisory Board to Help Advance Digital Dentistry
Stratasys Ltd., a leading global provider of 3-D printing and additive manufacturing solutions, recently announced it has established a dental advisory board to help advance digital dentistry.

With resources dedicated to collaboration, the Stratasys dental advisory board will pursue the following objectives:

  • Support research and development of Stratasys’ dental technologies and materials
  • Promote education and continued development for digital dental and orthodontic lab professionals
  • Forge relationships with industry organizations and allied dental technology providers for the benefit of dental and orthodontic labs
  • Promote Stratasys’ perspective to relevant industry groups, service providers and the labs community
  • Share best practices that enable 3-D printing technologies to take on a wider role in the dental lab environment

The Stratasys dental advisory board also aims to provide thought leadership and direction to the Stratasys dental business unit. It is expected to develop research and content that supports the evolution of Stratasys dental products and supports the roll-out of initiatives aimed to encourage dental education, clinical cases, and future innovation.

“We’re committed to adding value to the dental lab community by developing innovative 3D printers and materials that spur lab business growth,” says Stratasys director of global dental Avi Cohen. “Establishing the dental advisory board is a first step in supporting industry trends and future needs that represent the unique dental labs community.”

PEOPLE:

ADA
Dr. Eugenio Beltran
Senior Director of the Center For Scientific Strategies & Information
Eugenio Beltran, DMD, MPH, MS, DrPH, DABDPH, has accepted the position of the senior director, Center for Scientific Strategies & Information. Dr. Beltran will oversee activities of the Council on Scientific Affairs; identify emerging issues, assess and evaluate the scientific basis, clinical relevance, and member value for issues; and guide the programs of the ADA’s Science Institute, including the Center for Evidence-Based Dentistry, Center for Product Evaluation, Professional Product Review under the Center for Scientific Information.

He comes from the CDC, where he served as the senior scientist and advisor to the director, Division of Oral Health. Most recently, he was responsible for collating the scientific evidence for CDC’s evaluation of recommendations for fluoride in drinking water for the U.S. Prior to the CDC, Dr. Beltran spent several years conducting research at the University of Michigan School of Dentistry and School of Public Health and Institute for Social Research.

LED Imaging
Tom Kearney
Director of Corporate Events
In his new role, Kearney will help establish strong relationships with practice consultants to further build out LED Imaging’s customer base. He will also work to maximize corporate sponsorships, partnerships, and other industry relationships. Prior to joining LED Imaging, Kearney most recently served as the director of corporate events for Carestream Dental, applying his decades of corporate events and tradeshow experience to cultivating strong relationships with customers. Kearney, an original founder of OrthoTrac software, helped establish the product as a premier orthodontic practice management software around the world in markets such as the U.S., the United Kingdom, and Australia. His experience will serve him well as he supports LED Imaging in launching digital imaging and software produc